A surrogate endpoint is a biomarker intended to substitute for a clinical endpoint. In the context of cancer, surrogate endpoints are frequently used in clinical trials to measure the effect of a specific treatment. They are often used because they can be measured sooner or more easily than clinical endpoints, such as overall survival or quality of life.
